↓ Skip to main content

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients

Overview of attention for article published in Frontiers in immunology, June 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
126 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
Published in
Frontiers in immunology, June 2021
DOI 10.3389/fimmu.2021.704773
Pubmed ID
Authors

Emanuel Zitt, Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Beatrix Mutschlechner, Hanno Ulmer, Magdalena A. Benda, Hannelore Sprenger-Mähr, Thomas Winder, Karl Lhotta

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 126 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 13%
Student > Master 13 10%
Student > Ph. D. Student 9 7%
Student > Postgraduate 6 5%
Professor 5 4%
Other 16 13%
Unknown 60 48%
Readers by discipline Count As %
Medicine and Dentistry 35 28%
Nursing and Health Professions 9 7%
Immunology and Microbiology 4 3%
Biochemistry, Genetics and Molecular Biology 3 2%
Agricultural and Biological Sciences 2 2%
Other 13 10%
Unknown 60 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2022.
All research outputs
#15,181,325
of 25,392,582 outputs
Outputs from Frontiers in immunology
#14,214
of 31,541 outputs
Outputs of similar age
#215,475
of 445,312 outputs
Outputs of similar age from Frontiers in immunology
#682
of 1,456 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,312 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,456 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.